Patient Access Solutions, Inc. and iMedicor Form Strategic Alliance
August 16 2010 - 10:00AM
Marketwired
Patient Access Solutions, Inc. (PINKSHEETS:
PASO), a leading provider of information technology solutions for
the healthcare industry announced today a partnership with
iMedicor (OTCBB: VMCI). The partnership will
provide a complementary synergy of combined products and services
that will enable enhanced information exchange capabilities by
integrating the iMedicor portal with Patient Access Solution's
digital pen technology for the home healthcare industry and robust
HIPAA transaction processing and reporting platform. In addition,
Patient Access Solution's 4000+ users will have access to
iMedicor's ClearLobby platform that will provide informative,
product specific content on new drugs and medical devices enabling
users to directly communicate electronically with the manufacturers
to order samples, ask questions and set up onsite meetings.
ClearLobby establishes an additional revenue driver and value added
solution to users by providing access to the recently announced
National health information exchange and the National Healthcare
Communications Network (NHCN).
Both companies are pleased to announce the Alliance's first
opportunity, a 5,000 member healthcare provider group, has entered
its implementation phase and scheduled to be live by Q4, 2010.
Conservative projections estimate recurring gross annual revenue of
over $1,000,000 throughout the PASO user base.
iMedicor's pharma marketing platform, "ClearLobby," offers the
first of its kind physician / pharma electronic communication
system resulting in interactions that are much more meaningful and
efficient. ClearLobby changes the dynamic of these relationships by
placing control squarely in the hands of the physician. At the same
time, the interaction between the physician and the pharma becomes
more cost effective because ClearLobby is able to distribute
critical product information and samples directly to the targeted
user base.
"We are excited about the strategic partnership we've developed
with iMedicor. Their ClearLobby solution interfaced with our
technology will provide the healthcare industry with a secure,
robust, dynamic information and messaging platform. Being able to
develop a mutually beneficial recurring revenue business model
creates a win-win for both organizations," said CEO Bruce
Weitzberg.
"This alliance is another major step in launching our National
Health Information Exchange and will go a long way in supporting
and making a reality of the National Healthcare Communication
Network," said Fred Zolla, iMedicor's CEO. "This is a great
opportunity for two up and coming companies."
About iMedicor
iMedicor is the only HIPAA-compliant solution for interoperable
medical information transfer that is offered to healthcare
providers and patients. The iMedicor portal also enables doctors,
administrators and other qualified healthcare workers to send and
receive medical records, files and images in a secure, HIPAA
compliant environment; allows disparate EMR (electronic medical
record) systems to communicate, collaborate and exchange records in
real time; and allows pharmaceutical companies to deliver
customized marketing programs to healthcare providers nationwide in
a highly targeted, cost-effective and non-intrusive manner. More
information on iMedicor is available at www.imedicor.com.
About Patient Access Solutions, Inc.
Patient Access Solutions, Inc. (PAS) is a Healthcare Solutions
Company which has created a formidable array of technology,
resources and allies to enable it to become an agent of radical
change in what has traditionally been a slowly evolving healthcare
information technology environment. The Company's products are
designed to allow health care providers an easy migration to the
EMR environment. Among these products are D-PAS, which is a
state-of-the-art digital pen and paper technology based on Anoto
technology, used to capture hand written information into digital
forms and EMR systems and PAS Data Center, which is a terminal
solution that allows health care providers to quickly and easily
determine benefit eligibility. More information on Patient Access
Solutions, Inc. and its products can be viewed at
www.pashealth.com.
Certain statements in this news release may contain
forward-looking information within the meaning of Rule 175 under
the Securities Act of 1933 and Rule 3b-6 under the Securities
Exchange Act of 1934, and are subject to the safe harbor created by
those rules. All statements, other than statements of fact,
included in this release, including, without limitation, statements
regarding potential future plans and objectives of the companies,
are forward-looking statements that involve risks and
uncertainties. There can be no assurance that such statements will
prove to be accurate and actual results and future events could
differ materially from those anticipated in such statements.
Factors that could cause actual results to differ materially from
those in the forward-looking statements include, among other
things, the following: general economic and business conditions;
competition; unexpected changes in technologies and technological
advances; ability to commercialize and manufacture products;
results of experimental studies; research and development
activities; changes in, or failure to comply with, governmental
regulations; and the ability to obtain adequate financing in the
future. This information is qualified in its entirety by cautionary
statements and risk factors disclosure contained in certain of
Patient Access Solutions Inc. Securities and Exchange Commission
filings available at http://www.sec.gov.
Investor and Media Contact: Craig StoutChief
Operating Officer (845) 356-5211 cstout@vemics.com
Patient Access Solutions (CE) (USOTC:PASO)
Historical Stock Chart
From Apr 2024 to May 2024
Patient Access Solutions (CE) (USOTC:PASO)
Historical Stock Chart
From May 2023 to May 2024